Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AVTX

Avalo Therapeutics Inc

May 13 • 04:00PM ET

19.85

-0.09 -0.45 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: ZURA COGT AUPH KYTX ARQT

| Held by: VTI VXF IWC ITOT TMSL DFAS DFMC TMED BMED TNXT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.10	Insider Own	9.98%	Shs Outstand	26.71M	Perf Week	-8.99%
Market Cap	530.28M	Forward P/E	-	EPS next Y	-3.37	Insider Trans	-10.91%	Shs Float	24.05M	Perf Month	42.81%
Enterprise Value	434.34M	PEG	-	EPS next Q	-0.67	Inst Own	72.32%	Short Float	23.84%	Perf Quarter	38.33%
Income	-78.26M	P/S	8837.93	EPS this Y	44.45%	Inst Trans	25.13%	Short Ratio	4.37	Perf Half Y	30.46%
Sales	0.06M	P/B	4.42	EPS next Y	-3.78%	ROA	-58.31%	Short Interest	5.73M	Perf YTD	9.31%
Book/sh	4.49	P/C	5.39	EPS next 5Y	21.02%	ROE	-72.43%	52W High	24.27 -18.21%	Perf Year	439.40%
Cash/sh	3.68	P/FCF	-	EPS past 3/5Y	82.35% 70.20%	ROIC	-91.98%	52W Low	3.39 485.55%	Perf 3Y	-96.64%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-85.16% -61.19%	Gross Margin	-483.05%	Volatility	9.21% 9.90%	Perf 5Y	-99.69%
Dividend TTM	-	EV/Sales	7238.93	EPS Y/Y TTM	95.62%	Oper. Margin	-123601.69%	ATR (14)	1.74	Perf 10Y	-99.82%
Dividend Ex-Date	-	Quick Ratio	8.14	Sales Y/Y TTM	-86.62%	Profit Margin	-132642.37%	RSI (14)	62.78	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.14	EPS Q/Q	78.04%	SMA20	22.20%	Beta	0.85	Target Price	46.64
Payout	-	Debt/Eq	0.03	Sales Q/Q	-69.27%	SMA50	26.78%	Rel Volume	1.19	Prev Close	19.94
Employees	33	LT Debt/Eq	0.02	Earnings	May 13 BMO	SMA200	34.41%	Avg Volume	1.31M	Price	19.85
IPO	Nov 13, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.42% -	Trades		Volume	1,556,088	Change	-0.45%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)